Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,880 | 8,310 | 4,950 | 6,400 | 7,530 |
| Receivables | 40 | 40 | 40 | 30 | 30 |
| Other current assets | 90 | 90 | 90 | 120 | 20 |
| TOTAL | $7,010 | $8,440 | $5,080 | $6,550 | $7,580 |
| Non-Current Assets | |||||
| Investments And Advances | 5,000 | 5,000 | 3,170 | 3,190 | 0 |
| TOTAL | $5,000 | $5,000 | $3,170 | $3,190 | $N/A |
| Total Assets | $16,700 | $17,960 | $11,090 | $12,510 | $10,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 860 | 1,260 | 470 | 480 | 590 |
| TOTAL | $860 | $1,260 | $470 | $690 | $590 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 150 | 0 | 90 | 90 |
| Other Non-Current Liabilities | 150 | 0 | 190 | 0 | 300 |
| TOTAL | $150 | $150 | $190 | $90 | $390 |
| Total Liabilities | $1,010 | $1,410 | $670 | $790 | $990 |
| Shareholders' Equity | |||||
| Common Shares | 30,550 | 30,300 | 18,260 | 18,320 | 14,930 |
| Retained earnings | -17,560 | -16,450 | -9,540 | -8,300 | -7,290 |
| Other shareholders' equity | -10 | 0 | 0 | 0 | 0 |
| TOTAL | $15,680 | $16,550 | $10,410 | $11,720 | $9,200 |
| Total Liabilities And Equity | $16,690 | $17,960 | $11,080 | $12,510 | $10,190 |